Summer by Design: A launchpad for future entrepreneurs and industry scientists
Sylvia Almeida is a PhD candidate in the Department of Molecular Genetics at the University of Toronto. Her research leverages chemical genomics to uncover novel therapeutic strategies for human disease in collaboration with other Canadian and international academic...Commercializing regenerative medicine: My Summer by Design 2025 experience
Maria Tsalkitzidou is a PhD student at Lund University in Sweden. Her research focuses on neural stem cells and their potential for cell therapy applications for neurological disorders. She specializes in using advanced multiomic techniques to study and characterize...The impact of IPOs on biotech market expansion: Strategies and projections
The biotechnology sector has always been a hub of innovation, consistently pushing the boundaries of scientific and technological advancements. However, transforming novel discoveries into viable market-ready solutions requires substantial financial backing. Among the...From innovation to international impact: ARM’s 2025 “State of the Industry Briefing” showcases maturing CGT industry
2025 marks the third time I’ve covered the Alliance for Regenerative Medicine (ARM) State of the Industry Briefing for Signals. In 2024’s installation, I noted the strong emphasis on the cell and gene therapy (CGT) industry’s acceleration, driven by scientific...
Comments